Synbio Tech Inc.

TWO:1295 Taiwan Biotechnology
Market Cap
$21.20K
NT$701.49K TWD
Market Cap Rank
#43750 Global
#1940 in Taiwan
Share Price
NT$71.50
Change (1 day)
-0.28%
52-Week Range
NT$69.80 - NT$88.10
All Time High
NT$88.10
About

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional s… Read more

Synbio Tech Inc. - Asset Resilience Ratio

Latest as of September 2025: 3.51%

Synbio Tech Inc. (1295) has an Asset Resilience Ratio of 3.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$100.02 Million
Cash + Short-term Investments
Total Assets
NT$2.85 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2022)

This chart shows how Synbio Tech Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Synbio Tech Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$100.02 Million 3.51%
Total Liquid Assets NT$100.02 Million 3.51%

Asset Resilience Insights

  • Limited Liquidity: Synbio Tech Inc. maintains only 3.51% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Synbio Tech Inc. Industry Peers by Asset Resilience Ratio

Compare Synbio Tech Inc.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Synbio Tech Inc. (2020–2022)

The table below shows the annual Asset Resilience Ratio data for Synbio Tech Inc..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 11.34% NT$190.18 Million NT$1.68 Billion -2.28pp
2021-12-31 13.62% NT$208.84 Million NT$1.53 Billion +2.64pp
2020-12-31 10.99% NT$152.19 Million NT$1.39 Billion --
pp = percentage points